Search
 
Company

Biontech Ag

9 Case(s) (Last 5 Years)

Patents Prosecuted

Application numberTitle of the patentIPCFiling DateDecision Date
16374503 Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligands A61K, C07K Apr 2, 2019 Oct 19, 2020
16966422 TREATMENT USING CYTOKINE ENCODING RNA C07K, A61K Feb 7, 2019
16250366 Use of RNA for reprogramming somatic cells C12N Jan 16, 2019 May 17, 2021
16245353 Method for cellular RNA expression C12P, A61K, C12N Jan 10, 2019 Aug 3, 2020
16229841 Tumor antigens for determining cancer therapy C12Q, G01N, C07K, A61K Dec 20, 2018 Apr 17, 2023
16172063 Individualized vaccines for cancer A61K, A61P Oct 25, 2018 Nov 21, 2022
16757054 Preparation and storage of liposomal RNA formulations suitable for therapy A61K, B82Y Oct 17, 2018 Jul 25, 2022
16143520 Modification of RNA, Producing an Increased Transcript Stability and Translation Efficiency C12N Sep 26, 2018
16478615 Engineered Cells for Inducing Tolerance A61P, A61K, C07K, C12N Sep 16, 2018
16646313 METHOD OF ENHANCING RNA EXPRESSION IN A CELL C12N, C07K Sep 10, 2018
16645707 RNA REPLICON FOR REPROGRAMMING SOMATIC CELLS C12N Sep 10, 2018
16644079 Substituted imidazoquinolines as agonists of TLR7 C07D, A61P Aug 30, 2018 Mar 21, 2022
16644076 Substituted imidazoquinolines A61P, C07D Aug 30, 2018 Mar 7, 2022
29658889 Hydrogen water generator Aug 2, 2018 May 25, 2020
16619761 Methods for characterizing loss of antigen presentation C12Q May 31, 2018 Mar 4, 2024
16620459 METHODS FOR PREDICTING THE USEFULNESS OF DISEASE SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY G01N, A61K May 31, 2018
16500005 RNA for treatment of autoimmune diseases A61P, C12N, A61K Apr 9, 2018 Jul 17, 2023
16500707 PROTEIN ANTIGENS AND USES THEREOF A61P, A61K Apr 2, 2018
16496858 Methods and compositions for stimulating immune response C12N, A61K Mar 20, 2018 Oct 17, 2022
15922433 Particles comprising a shell with RNA A61K, C12N Mar 14, 2018 Mar 2, 2020
Menu